Version 1
: Received: 31 August 2020 / Approved: 1 September 2020 / Online: 1 September 2020 (12:24:09 CEST)
Version 2
: Received: 22 December 2020 / Approved: 23 December 2020 / Online: 23 December 2020 (11:19:38 CET)
How to cite:
Schwarz, J.; Lütz, S. Triaging of Culture Conditions for the Enhanced Discovery of Secondary Metabolites from Different Bacteria. Preprints2020, 2020090019. https://doi.org/10.20944/preprints202009.0019.v1
Schwarz, J.; Lütz, S. Triaging of Culture Conditions for the Enhanced Discovery of Secondary Metabolites from Different Bacteria. Preprints 2020, 2020090019. https://doi.org/10.20944/preprints202009.0019.v1
Schwarz, J.; Lütz, S. Triaging of Culture Conditions for the Enhanced Discovery of Secondary Metabolites from Different Bacteria. Preprints2020, 2020090019. https://doi.org/10.20944/preprints202009.0019.v1
APA Style
Schwarz, J., & Lütz, S. (2020). Triaging of Culture Conditions for the Enhanced Discovery of Secondary Metabolites from Different Bacteria. Preprints. https://doi.org/10.20944/preprints202009.0019.v1
Chicago/Turabian Style
Schwarz, J. and Stephan Lütz. 2020 "Triaging of Culture Conditions for the Enhanced Discovery of Secondary Metabolites from Different Bacteria" Preprints. https://doi.org/10.20944/preprints202009.0019.v1
Abstract
Over the past decade, the One Strain Many Compounds (OSMAC) approach has been established for silent gene cluster activation and elicitation of secondary metabolite production, but so far the full secondary metabolome of a biosynthetically promising bacterium has not been elucidated yet. Here, we investigate the ability of seven categories of OSMAC conditions to elicit new mass features from bacterial strains with little literature coverage but high biosynthetic potential. The strains B. amyloliquefaciens DSM7, C. coralloides DSM2259, P. fallax HKI727, R. jostii DSM44719 and S. griseochromogenes DSM40499 were selected after genome mining with antiSMASH. After cultivation under OSMAC conditions, the generated extracts were subjected to LC/MS and MZmine analysis to determine new mass features, expressed gene clusters and evaluate the tested culture conditions. 4 predicted compounds, bacillibactin, desferrioxamine B, myxochelin A and surfactin, were identified and up to 147 new mass features were detected in the generated extracts, which greatly surpasses the number of predicted gene clusters. Among the new mass features are bioactive compounds which were so far unreported for the strains such as cyclo-(Tyr-Pro) from DSM7 and nocardamin from DSM2259. Furthermore, the tested culture conditions were evaluated regarding their suitability for the generation of new mass features from the selected strains and promising new starting points for further screenings are postulated. Especially culture conditions with little prior literature coverage are responsible for the activation of secondary metabolite production.
Biology and Life Sciences, Biology and Biotechnology
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
